PTC124-GD-021-CF: A Phase 3 Efficacy and Safety Study of Ataluren (PTC124®) in Patients with Nonsense Mutation Cystic Fibrosis (ACT CF)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/1412/31/17

Funding

  • PTC Therapeutics, Inc.